Delivery Order SPE2DB20D2014-SPE2DB24FD06X

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK medication, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $52,113.13 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024 with a completion date of October 23, 2024. This delivery order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $20,111.01, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,241.15 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,400.82. This is a firm fixed-price delivery order contract with a completion date of July 23, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $16,394.75 for ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $6,361.17 firm fixed-price delivery order has a January 2024 award date and an ultimate completion date of January 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $8,379.05 and is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,878.03 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 13, 2024. The contract has an ultimate completion date of June 14, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK medication to the Defense Logistics Agency (DLA), a defense agency. The $30,100.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a June 13, 2025 completion date and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD06X
    Delivery Order

This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,400.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to military treatment programs and facilities worldwide. The contract has no set-aside designation and was awarded on September 18, 2024, with a completion date of September 19, 2024.

Generated 12/18/24, 9:28 AM